Sign in

CIK 0002012593

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Rapport Therapeutics, Inc.

Sign in to watch
Ticker
RAPP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
880724208
Phone
+1 857-321-8020
Business address
99 HIGH STREET, SUITE 2100, BOSTON, MA, 02110
Former names
Rapport Therapeutics, Inc.
Open-market buys, last 90 days
$22,023,904
in 7 filings
Open-market sales, last 90 days
$4,490,340
in 8 filings, $4.5M under 10b5-1 plans

Net +$17,533,565. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-10-30 Third Rock Ventures V, L.P. Director Grant or award +238,095 $21.00 $5.0M 6,518,620
2026-10-30 Third Rock Ventures V, L.P. Director Grant or award +1,190,476 $21.00 $25.0M 2,159,694
2026-05-26 Third Rock Ventures V, L.P. 10% owner Sale 10b5-1 −18,572 $40.05 $744K 6,280,525
2026-05-11 Third Rock Ventures V, L.P. 10% owner Sale 10b5-1 −133,618 $40.24 $5.4M 6,299,097
2026-05-08 Third Rock Ventures V, L.P. 10% owner Sale 10b5-1 −5,018 $40.31 $202K 6,432,715
2026-05-07 Third Rock Ventures V, L.P. 10% owner Sale 10b5-1 −271,495 $40.12 $10.9M 6,437,733
2026-04-17 Third Rock Ventures V, L.P. 10% owner Sale 10b5-1 −426,005 $40.32 $17.2M 6,709,228
2024-06-10 Third Rock Ventures V, L.P. 10% owner Conversion +6,551,449 7,135,233
2024-06-10 Third Rock Ventures V, L.P. 10% owner Conversion +969,218 969,218
2024-06-10 Third Rock Ventures V, L.P. 10% owner Conversion · Series A Preferred Stock −56,091,177 0
2024-06-10 Third Rock Ventures V, L.P. 10% owner Conversion · Series A Preferred Stock −8,000,000 0
2024-06-10 Third Rock Ventures V, L.P. 10% owner Conversion · Series B Preferred Stock −298,103 0

Page 1 of 1 · 12 trades